Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Long-term Solutions for Long-term Diseases: Using Long-Acting Injectable Antipsychotics in Practice

Listen as Leslie Citrome, MD, MPH, and Adam Lowy, MD, share information on long-acting injectable antipsychotics ranging from pharmacokinetic properties to strategies on incorporating these agents into clinical practice.
Leslie Citrome, MD, MPH
person default
Adam Lowy, MD
Released: January 18, 2023

In this podcast episode, Leslie Citrome, MD, MPH, and Adam Lowy, MD, share a wealth of knowledge about long-acting injectable (LAI) antipsychotics. Their conversation begins with an overview of the pharmacokinetic profiles of LAI antipsychotics and how they differ from their oral counterparts, as well as injection intervals available with current formulations. The experts also discuss the clinical utility of LAI antipsychotics in psychiatry practice, highlighting their role in assuring medication adherence and their application in both first- and later-episode psychosis. Finally, Drs Citrome and Lowy hit on practical aspects of incorporating LAI antipsychotics into patient care: communicating with patients to dispel myths and stigma surrounding injectable medications, identifying injection resources in your medical community, and strategies to navigate insurance barriers.

Throughout the podcast, Drs Citrome and Lowy reference several links to outside sources that can provide valuable education on LAI antipsychotics. Those links are listed below for your convenience.

Administering LAI Into Dorsal Gluteal Site: 
https://bit.ly/3XjSm5a

Administering LAI Into Deltoid Site: 
https://bit.ly/3Xlyq1L

Administering LAI Into Abdominal Site: 
https://bit.ly/3wgGJ2Z

Information on this Educational Activity

Faculty

Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Leslie Citrome, MD, MPH: consultant: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Lyndra, Medavante-ProPhase, Marvin, Merck, Mitsubishi-Tanabe Pharma, Neurocrine, Neurelis, Novartis, Noven, Otsuka, Ovid, Praxis, Recordati, Relmada, Reviva, Sage, Sunovion, Supernus, Teva; speaker: AbbVie/Allergan, Acadia, Alkermes, Angelini, Axsome, BioXcel, Eisai, Idorsia, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Recordati, Sage, Sunovion, Takeda; individual publicly traded stocks and stock options: Bristol-Myers Squibb, Johnson & Johnson, Lilly, Merck, Pfizer.
Adam Lowy, MD

Staff Psychiatrist
Ellenhorn
Los Angeles, California

Adam Lowy, MD: consultant/advisor/speaker: Alkermes, Axsome, Neurocrine.

Program Medium

This program has been made available online.

Acknowledgements

Supported by an educational grant from
Otsuka America Pharmaceutical, Inc. and Lundbeck

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings